Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 6Oropharyngeal Neoplasms 5Uterine Cervical Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Hypopharyngeal Neoplasms 3Radiation Injuries 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Laryngeal Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Sinonasal Squamous Cell Carcinoma 1Rectal Malignant Neoplasms 1Postoperative Complications 1Pathologic Complete Response 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ototoxicity 1Neoplasms 1Myelosuppression 1Mouth Neoplasms 1Margins of Excision 1Malignant Tumor of Lacrimal Drainage Structure 1Low Anterior Resection Syndrome 1Locally Advanced Hypopharyngeal Carcinoma 1

Interventions

Carboplatin 4pertuzumab 2durvalumab 2Tretinoin 2Trastuzumab 2Standard of Care 2Paclitaxel 2Oxaliplatin 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1toripalimab 1tislelizumab 1talazoparib 1sarilumab 1relugolix 1regorafenib 1pexidartinib 1pembrolizumab 1patritumab 1olaparib 1niraparib 1nimotuzumab 1neratinib 1ganitumab 1enzalutamide 1dostarlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pathologic Complete Response × Chemoradiotherapy × Clear all
NCT06647680 2026-03-06

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)

The Affiliated Hospital of Qingdao University

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡